Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody.
Regulation of ceramide synthase 6 in a spontaneous experimental autoimmune encephalomyelitis model is sex dependent.
Multiple sclerosis in children and adolescents: incidence and clinical picture - new insights from the nationwide German surveillance (2009-2011).
Immunomodulatory Effects of Histone Deacetylase Inhibitors.
Imaging of neuroinflammation in Alzheimer's disease, multiple sclerosis and stroke: Recent developments in positron emission tomography.
Active Biotech's partner Teva initiates a laquinimod clinical trial in Huntington's disease
Investigation of the relationship between vitamin D and bone mineral density in newly diagnosed multiple sclerosis.
HERVs in neuropathogenesis.
New-onset type 1 diabetes mellitus and anti-aquaporin-4 antibody positive optic neuritis associated with type 1 interferon therapy for chronic hepatitis C.
Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study.
The effects of aquatic therapy on mobility of individuals with neurological diseases: A systematic review.
Lower urinary tract symptoms of neurological origin in urological practice.
[Sociological research in Samara Oblast: a role of social organizations of patients in the improvement of quality of medical and social care].
Developing a community multiple sclerosis nursing service.
Voxelwise analysis of conventional magnetic resonance imaging to predict future disability in early relapsing-remitting multiple sclerosis.
[Sphingosine-1-phosphate signaling system and the innovative mechanism of action of fingolimod in treatment of multiple sclerosis: review of foreign literature.]
Fingolimod in active multiple sclerosis: an impressive decrease in Gd-enhancing lesions.
The TASK1 channel inhibitor A293 shows efficacy in a mouse model of multiple sclerosis.
Balò's concentric sclerosis: still to be considered as a variant of multiple sclerosis?
Unilateral thalamic deep brain stimulation for disabling kinetic tremor in multiple sclerosis.
Comparative validity of accelerometer based measures of physical activity for people with multiple sclerosis.
Evaluating treatment effect within a multivariate stochastic ordering framework: Nonparametric combination methodology applied to a study on multiple sclerosis.
Minocycline attenuates experimental autoimmune encephalomyelitis in rats by reducing T cell infiltration into the spinal cord.
The underdiagnosis of sleep disorders in patients with multiple sclerosis.
Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis.
Pages
« first
‹ previous
…
205
206
207
208
209
210
211
212
213
…
next ›
last »